Enquire Now
Enquire Apply
Dr HIMASAILA M

Dr HIMASAILA M View All

Assistant Professor

Apollo Institute of Pharmaceutical Sciences

Dr. HIMA SAILA.M is a graduate from_Nirmala College of Pharmacy, (JNTUA University) college and a Post Graduate from KLE College of Pharmacy, KLE University, Belgaum. She earned her Ph.D. from Sri Padmavati Mahila Visva Vidyalayam (Mahila University), Tirupati. She has also obtained additional qualifications/specializations in a diploma in clinical research.

Dr. Himasaila. M has over 10 years and 8 months of teaching experience. She has supervised over 10 batches of UG projects and 10 students at PG Levels. She has played various administrative roles such as Head of the Department, external Examiner, and in charge of NAAC and NBA, member of the Academic Council.

she has published 18 articles in International and National Journals, and has 2patents. She has written 3 books/e-book chapters. She has organized one Faculty Development Program, three Workshops. She served as a Reviewer of IBRO neuroscience reports and the Journal of Pharmaceutical Research International.

    • Graduation In :

      Pharmacy

    • Graduation From :

      Jawaharlal Nehru Technological University, Anantapur

    • Graduation Year :

      2009

    • Post Graduation In :

      Pharmacology

    • Post Graduation From :

      KLE College of Pharmacy, KLE University, Belgaum

    • Post Graduation Year :

      2011

    • Doctorate In :

      Pharmaceutical Sciences

    • Doctorate From :

      Sri Padmavati Mahila Visva Vidyalayam, Tirupati

    • Doctorate Year :

      2024

    • 10 Yrs 8 Months

  • Book Chapters:

    • Anti-aging Pharmacology: Advances and prospects in the book Drug Discovery” as a book chapter in the book titled Anti-aging Approaches for Human Longevity (Scopus indexed). IGI Global Scientific Publishing.
    • Targeting the Brain through the Skin: Innovative Transdermal Strategies for Alzheimer’s Therapy as a book chapter in Contemporary Research Reflections, CIRS Publications.
    • Prevalence and Risk Assessment of Diabetic Retinopathy in Type 2 Diabetic Patients as a book chapter in Contemporary Research Reflections, CIRS Publications.

    Publications in Journals:

    • Mukkudiahgari Hima Saila, Thakur S, Kudamala RR. Thymol Improves Brain Functional Outcomes After Cerebral Ischemia-Reperfusion Injury by Regulating p38 MAPK-Associated Apoptosis Signalling Pathway. Indian J of Pharmaceutical Education and Research. 2025;59(2):1-10. (SCOPUS, SCEI, WOS). Q3
    • Transanethole protects against Global Cerebral Ischemia through its Anti-inflammatory and Anti-apoptotic activity. Research Journal of Pharmacy and Technology, Vol 15 (4) 2022. (Scopus) Q2
    •  Molecular docking analysis of phytoconstituents of Illicium verum fruit against Caspase 3, MMP-9 and TNF-α. Indian Journal of Biochemistry & Biophysics Vol. 58, December 2021, pp. 510-519. (Scopus) Q2
    • N-Ethyl-N-Nitrosourea (ENU) induced Osteoporosis in Rats by inducing mutation in Collagen Type 1 protein–A Novel Method Development. Research Journal of Pharmacy and Technology, Vol 15 (8) 2022 (Scopus). Q2
    • Artificial Intelligence in Green Organic Chemistry: Pathway to Sustainable and Eco-Friendly Chemistry. Asian Journal of Chemistry; Vol. 36, No. 12 (2024), 2731-2743 (SCOPUS). Q4
    • Role of Chromosomal Instability in Cancer – An Update. Asian Journal of Pharmaceutics (AJP), 19(2). https://doi.org/10.22377/ajp.v19i2.6447.2025 (WOS).
    • Phyto-Based Iron Supplementation: Development and Evaluation of a Hematinic Herbal Tea. Asian Journal of Pharmaceutics (AJP), 19(2). https://doi.org/10.22377/ajp.v19i2.6447.2025 (WOS).
    • Evaluation of anti-thrombotic activity of chrysanthemum indicum flowers- an in vitro study. International Journal of Biology, Pharmacy and Allied Sciences. June 2025. (WOS)
    • The neuroprotective outcome of thymol against global cerebral ischemia-reperfusion injury in albino rats. Journal of Pharmaceutical Research International, 33 [Issue 38A]:38-48.2021. (SCI)
    • Protective effect of trans-anethole on brain ischemia-reperfusion injury in rats induced by bilateral common carotid artery occlusion. Advances in bioresearch, Vol 12 (4); 192-198. 2021. (WOS).
    • A retrospective study on antibiotics use in pediatric patients at a tertiary care teaching hospital. International Journal of Research and Analytical Reviews. Vol 9 (2), 2022 454-459.(UGC)
    • Pharmacological evaluation of piracetam and vanadyl sulfate on experimentally induced cerebral ischemia in rats. International journal of pharmacy and pharmaceutical sciences, 2016, 8(9):178-181 (UGC)
    • The anti-osteoporotic activity of ethanolic leaves extract of Vitex leucoxylon against chronic alcoholic abuse model-induced osteoporosis in rats. Journal of Global Trends in Pharmaceutical Sciences, 2015, 6(3): 2854-2859.
    • Network Pharmacology-based approach to explore potential targets of punchaskar churn on constipation and piles, Bulletin of Environment, Pharmacology and Life Sciences (BELPS).Vol 12 (12) 2023.(WOS)
    • Evaluation of in vitro anti-obesity activity of ethanolic seed extract of cassia tora L. Bulletin of Environment, Pharmacology and Life Sciences (BELPS). Vol 12 (10/11) 2023. (WOS).
    • Treatment approaches for the COVID 19. Journal of Xidian University, Vol 17(3),2023.
    • Hormone Replacement therapy in postmenopausal women-A review, YMER, vol 22(02),2023.
    • Gene Therapy in the treatment of leukemia review-YMER, vol 22(02),2023

    Publications in Conferences:

    • Molecular docking analysis of phytoconstituents of Illicium verum fruit against Caspase 3, MMP-9 and TNF-α. Indian Journal of Biochemistry & Biophysics Vol. 58, December 2021, pp. 510-519. (Scopus) Q2

    Patents:

    • 1. Artificial intelligence-based device for calculating the absorbance of drugs Design no: 6364225 Grant date: 15 May 2024.
    • 2. Apparatus for instant isolation of active constituents from natural compounds. Design no: 414324-001 Grant date: 24 April 2024